Altered shape and cell cycle characteristics of fibroblasts expressing the E2F1 transcription factor - PubMed (original) (raw)
Altered shape and cell cycle characteristics of fibroblasts expressing the E2F1 transcription factor
T J Logan et al. Mol Biol Cell. 1994 Jun.
Free PMC article
Abstract
To gain an understanding of the role the E2F1 transcription factor plays in cell physiology, the full length protein (E2F1) and an amino terminal deletion of 87 amino acids (E2F1d87) were constitutively expressed in NIH3T3 fibroblasts. Multiple cell lines were generated for each construct. These cells do not proliferate in media containing low serum and do not proliferate in soft agar, indicating that they are likely not transformed. However, both sets of cell lines show increased DNA synthesis and increased numbers of cells in S phase when cultured in media containing low serum, compared to the control cell lines. Cells expressing E2F1d87 (but not E2F1) have an extremely rounded morphology when cultured in 10% serum-containing media. These rounded cells lack detectable microfilaments, microtubules, and focal contacts. However, when these cells are cultured in low serum-containing media (0.5%), they attain the flattened morphology and cytoskeletal structure of normal NIH3T3 cells.
Similar articles
- Altered cell shape is linked to increased p34cdc2 gene expression in fibroblasts expressing a mutant E2F-1 transcription factor.
Logan TJ, Jordan KL, Evans DL, Hall DJ. Logan TJ, et al. J Cell Biochem. 1997 Apr;65(1):83-94. J Cell Biochem. 1997. PMID: 9138083 - A mutant E2F-1 transcription factor that affects the phenotype of NIH3T3 fibroblasts inefficiency associates with cyclin A-cdk2.
Jordan-Sciutto KL, Hall DJ. Jordan-Sciutto KL, et al. Biochem Cell Biol. 1998;76(1):37-44. Biochem Cell Biol. 1998. PMID: 9666304 - Regulation of the G1/S transition phase in mesangial cells by E2F1.
Inoshita S, Terada Y, Nakashima O, Kuwahara M, Sasaki S, Marumo F. Inoshita S, et al. Kidney Int. 1999 Oct;56(4):1238-41. doi: 10.1046/j.1523-1755.1999.00705.x. Kidney Int. 1999. PMID: 10504464 Review. - Why size matters: altering cell size.
Saucedo LJ, Edgar BA. Saucedo LJ, et al. Curr Opin Genet Dev. 2002 Oct;12(5):565-71. doi: 10.1016/s0959-437x(02)00341-6. Curr Opin Genet Dev. 2002. PMID: 12200162 Review.
Cited by
- PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A.
Altiok S, Xu M, Spiegelman BM. Altiok S, et al. Genes Dev. 1997 Aug 1;11(15):1987-98. doi: 10.1101/gad.11.15.1987. Genes Dev. 1997. PMID: 9271121 Free PMC article. - Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1.
Wu CL, Classon M, Dyson N, Harlow E. Wu CL, et al. Mol Cell Biol. 1996 Jul;16(7):3698-706. doi: 10.1128/MCB.16.7.3698. Mol Cell Biol. 1996. PMID: 8668186 Free PMC article. - Characterization of the nonmuscle myosin heavy chain IIB promoter: regulation by E2F.
Weir L, Chen D. Weir L, et al. Gene Expr. 1996;6(1):45-57. Gene Expr. 1996. PMID: 8931991 Free PMC article. - Comparative proteomics of paired vocal fold and oral mucosa fibroblasts.
Karbiener M, Darnhofer B, Frisch MT, Rinner B, Birner-Gruenberger R, Gugatschka M. Karbiener M, et al. J Proteomics. 2017 Feb 23;155:11-21. doi: 10.1016/j.jprot.2017.01.010. Epub 2017 Jan 15. J Proteomics. 2017. PMID: 28099887 Free PMC article. - E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis.
Nip J, Strom DK, Fee BE, Zambetti G, Cleveland JL, Hiebert SW. Nip J, et al. Mol Cell Biol. 1997 Mar;17(3):1049-56. doi: 10.1128/MCB.17.3.1049. Mol Cell Biol. 1997. PMID: 9032231 Free PMC article.
References
- Cell. 1990 Jan 12;60(1):151-65 - PubMed
- J Cell Physiol. 1989 Oct;141(1):154-9 - PubMed
- EMBO J. 1990 Jul;9(7):2179-84 - PubMed
- J Cell Biol. 1990 Jul;111(1):95-102 - PubMed
- Nature. 1990 Jul 5;346(6279):76-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources